Veeco-Axcelis Merger Wins Shareholder Nod, Faces Final China Hurdle

PLAINVIEW, NY – February 06, 2026 – Veeco Instruments Inc. announced today that its stockholders have overwhelmingly approved the company’s pending merger with Axcelis Technologies, a critical milestone that brings the creation of a new semiconductor equipment powerhouse one step closer to reality. The positive vote, echoed by Axcelis shareholders, sent shares of both companies climbing, reflecting strong investor confidence in the deal's strategic logic.

However, the celebration is tempered by a significant and unpredictable final obstacle. The roughly $4.4 billion enterprise-value transaction now awaits a single, final green light from the State Administration for Market Regulation (SAMR) of the People’s Republic of China. With the deal’s fate resting in the hands of Beijing’s regulators, the merger has become a high-profile test case for global M&A amidst escalating geopolitical and technological rivalries.

A Resounding Vote of Confidence

At a special meeting held today, Veeco stockholders demonstrated powerful support for the transaction. According to the company, of the approximately 89.37% of voting power present, over 53.4 million votes were cast in favor of the merger agreement, with fewer than half a million voting against. This decisive margin underscores a firm belief among investors in the value proposition of combining Veeco's broad manufacturing equipment portfolio with Axcelis's specialized technology.

The market reacted with immediate optimism. Following the announcement, Veeco (Nasdaq: VECO) shares closed nearly 6% higher, while Axcelis (Nasdaq: ACLS) shares rose 5.6%, with gains extending in after-hours trading.

The merger, first announced in the fall of 2025, aims to create a more formidable player in the highly competitive semiconductor equipment market. In a previous statement, Veeco CEO Dr. Bill Miller articulated the vision, stating the combination “capitalizes on the core competencies of both Veeco and Axcelis to address our customers' critical needs.” He emphasized that the increased scale would be a key driver of innovation, noting, “with increased R&D scale, the combination of these two exceptional businesses will accelerate our ability to solve material challenges, enable advanced chip manufacturing and build an even stronger company that can deliver superior value for all stakeholders.”

The Final Hurdle in Beijing

With all other major approvals secured, the spotlight now turns exclusively to China's SAMR. This final regulatory review is far from a simple administrative check. In recent years, SAMR's merger control process has evolved into a strategic lever for China, particularly for transactions within the sensitive semiconductor industry. The ongoing U.S.-China tensions over technology access and trade have transformed these reviews into complex negotiations that weigh national economic development and public interest alongside traditional antitrust concerns.

While the majority of merger filings in China are processed relatively quickly, deals involving strategic sectors like semiconductors are subject to heightened scrutiny and often face prolonged review timelines. The statutory review period can extend up to 180 days after a case is formally accepted, and a “stop-the-clock” mechanism introduced in 2022 allows the regulator to suspend the review indefinitely, creating further uncertainty. This tool was notably employed during the review of Broadcom's acquisition of VMware, which added months to the approval process.

Recent precedents suggest the path for Veeco and Axcelis could be complex. High-profile technology mergers, such as the Synopsys-Ansys deal, have been actively examined by SAMR, even when not meeting standard notification thresholds. In many cases, SAMR has granted conditional approval, imposing behavioral remedies that require the merged entity to guarantee supply, fair pricing, and historical volumes to Chinese customers. While SAMR has not blocked many major global deals, its willingness to intervene decisively, as seen in a 2025 order to unwind a domestic pharmaceutical merger, demonstrates its authority to reshape markets it deems critical.

Forging a Semiconductor Equipment Powerhouse

The strategic rationale driving the merger is rooted in technological synergy and market expansion. The combined company aims to provide a more comprehensive suite of tools for the world’s most advanced chipmakers. Veeco brings a diverse portfolio of process equipment, including its leading laser annealing, ion beam, MOCVD, and lithography technologies. These systems are essential for fabricating and packaging the complex chips that power modern electronics.

Axcelis, meanwhile, is a leader in ion implantation, a highly specialized and critical step in the chip manufacturing process where ions are embedded into silicon wafers to alter their electrical properties. By integrating Axcelis’s deep expertise in this area, the new entity will be able to offer customers a more complete and powerful set of solutions, particularly for high-growth markets like artificial intelligence (AI) and advanced power solutions.

Together, the companies project their total addressable market will expand to over $5 billion. Upon closing, the combined entity plans to adopt a new name, ticker symbol, and brand to signify its transformed identity. It will be headquartered in Beverly, Massachusetts, with Axcelis CFO James Coogan slated to serve as the chief financial officer of the new company. The stated goal is to build a more resilient and innovative company capable of navigating the immense technical challenges of next-generation semiconductor manufacturing.

Despite the strong internal momentum and shareholder backing, the companies maintain a cautious outlook on timing, reiterating their expectation that the merger will be completed in the second half of 2026. This timeline is now wholly contingent on the proceedings in Beijing. For investors, customers, and competitors, the coming months will be a period of watchful waiting, as the strategic vision for a new semiconductor leader confronts the intricate realities of global politics.